Tao Zeng

Dr. Tao Zeng

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TZTao Zeng
Tao Zeng
HGHongyi Gao
Hongyi Gao
PYPei Yu
Pei Yu
HHHeng He
Heng He
XOXiaoming Ouyang
Xiaoming Ouyang
YZYan Zhang
Yan Zhang
Kin17 is ubiquitously expressed at low levels in human tissue and participates in DNA replication, DNA repair and cell cycle control. Breast cancer cells are characterized by enabling replicative immortality and accumulated DNA damage. However, whether kin17 contributes to breast carcinogenesis remains unknown. In this study, we show for the first time that kin17 is an important molecule related to breast cancer. Our results show that kin17 expression was markedly increased in clinical breast tumors and was associated with tumor grade, Ki-67 expression, p53 mutation status and progesterone receptor expression, which were assessed in a clinicopathologic characteristics review. Knockdown of kin17 inhibited DNA replication and repair, blocked cell cycle progression and inhibited anchorage-independent growth, while increasing sensitivity to chemotherapy in breast cancer cells. Moreover, kin17 silencing decreased EGF-stimulated cell growth. Furthermore, overexpression of kin17 promoted DNA replication and cell proliferation in MCF-10A. Our findings indicate that up-regulation of kin17 is strongly associated with cellular proliferation, DNA replication, DNA damage response and breast cancer development. The increased level of kin17 was not only a consequence of immortalization but also associated with tumorigenesis. Therefore, kin17 could be a novel therapeutic target for inhibiting cell growth in breast cancer.

9 February 2017 in Oncology Letters
Verified
Journal Article
Open access
PDF file
YZYuzhao Zhang
Yuzhao Zhang
SHSenlin Huang
Senlin Huang
HGHongyi Gao
Hongyi Gao
KWKunhe Wu
Kunhe Wu
XOXiaoming Ouyang
Xiaoming Ouyang
TZTao Zeng
Tao Zeng
Kin17 DNA and RNA binding protein (Kin17) is a highly conserved protein that participates in DNA replication, DNA repair and cell cycle progression. Recently, the tumor-promoting function of Kin17 has been demonstrated and increasingly studied. In the present study, the role of Kin17 in the invasion and metastasis of non-small cells lung cancer (NSCLC) was investigated. Elevated Kin17 mRNA and protein expression was identified in a total of 97 NSCLC and benign lung lesion tissue specimens. Kin17 overexpression was significantly correlated with high tumor grade and lymph node metastasis, indicating poor patient prognosis. Scratch and Transwell assays demonstrated that the knockdown of KIN17 inhibited the ability of NSCLC cells to migrate and invade. Furthermore, reverse transcription-quantitative polymerase chain reaction and western blot analyses confirmed that knockdown of KIN17 decreased the expression of matrix metalloproteinase 7, epidermal growth factor receptor and v-myc avian myelocytomatosis viral oncogene homolog. The results of the present study indicate that Kin17 is markedly overexpressed in NSCLC tissues compared with benign lung lesion and peritumoral tissue. The upregulation of KIN17 may serve an important role in the metastasis of NSCLC cells. These results indicate that Kin17 is a novel diagnostic and prognostic biomarker of NSCLC, in addition to being a potential therapeutic target for the treatment of patients with NSCLC.

28 November 2022 in Talanta
Verified
Journal Article
Closed access
CZChuiyu Zhu
Chuiyu Zhu
XTXiao Tian
Xiao Tian
QLQiuyan Li
Qiuyan Li
ZDZichang Dai
Zichang Dai
LWLina Wang
Lina Wang
JZJunsong Zheng
Junsong Zheng

19 May 2021 in Thoracic Cancer
Verified
Journal Article
Open access
PDF file
QHQiyuan Huang
Qiyuan Huang
KZKashif Rafiq Zahid
Kashif Rafiq Zahid
JCJinsi Chen
Jinsi Chen
XPXiangxiong Pang
Xiangxiong Pang
MZMeifeng Zhong
Meifeng Zhong
TZTao Zeng
Tao Zeng
Background: Breast cancer (BC), the most common cause of cancer death in women, overtook lung cancer as the leading cause of cancer worldwide in 2020. Although many studies have proposed KIN17 as a biomarker of tumorigenesis in different cancer types, its role in tumor metastasis, particularly in BC metastasis, has been underexplored. This study aimed to explore the role of KIN17 in BC metastasis.Methods: Survival analyses was performed to identify the association between KIN17 expression and BC patient survival in silico. Using lentivirus constructs, we developed bidirectional KIN17 expression (KD, knockdown; OE, overexpression) cellular models of luminal‐A (Lum‐A) breast cancer MCF‐7 cells. We performed in vitro wound healing, transwell with and without Matrigel assays, and in vivo tail‐vein metastasis assay to evaluate the migration and invasion abilities of MCF‐7 with stable KIN17 knockdown or overexpression. Western blotting was performed to compare the changes in protein expression.Results: We found that KIN17 expression was associated with poor overall survival (OS), relapse‐free survival (RFS), distant metastasis‐free survival (DMFS) and post‐progression survival (PPS), particularly in Lum‐A breast cancer patients. Later, we found that KIN17 knockdown inhibited migration and invasion of MCF‐7 cells via regulating EMT‐associated signaling pathways in vitro and decreases metastatic spread of the disease in vivo. In contrast, KIN17 overexpression promoted migration and invasion of MCF‐7 cells in vitro and increased the metastatic spread of the disease in vivo.Conclusions: Overall, our findings provide preliminary data which suggests KIN17 of importance to target in metastatic Lum‐A patients.

1 May 2017 in International Journal of Gynecological Cancer
Verified
Journal Article
Closed access
PDF file
YZYuzhao Zhang
Yuzhao Zhang
HGHongyi Gao
Hongyi Gao
XGXiang Gao
Xiang Gao
SHSenlin Huang
Senlin Huang
KWKunhe Wu
Kunhe Wu
TZTao Zeng
Tao Zeng

18 October 2018 in Oncology Letters
Verified
Journal Article
Open access
PDF file
XGXiang Gao
Xiang Gao
ZLZhenping Liu
Zhenping Liu
MZMeifeng Zhong
Meifeng Zhong
KWKunhe Wu
Kunhe Wu
YZYuzhao Zhang
Yuzhao Zhang
TZTao Zeng
Tao Zeng
Effective therapy for breast cancer has been extensively studied worldwide, particularly for triple‑negative breast cancer and drug‑resistant subtypes. DNA/RNA‑binding protein KIN17 (kin17) has been reported to be significantly upregulated in breast cancer cells, and is proposed to serve a role in the regulation of cell proliferation. The present study further investigated the association of kin17‑knockdown with breast cancer cell apoptosis. Cell Counting kit‑8, flow cytometry, TUNEL assay and caspase 3/7 analysis were performed on MDA‑MB‑231 cells to determine the association between kin17 and breast cancer cell apoptosis. In addition, western blot analysis was performed to investigate the mechanism of kin17 in the apoptosis of MDA‑MB‑231 cells. The results revealed that knockdown of kin17 inhibited proliferation and promoted apoptosis of MDA‑MB‑231 cells, and suggested a poly (adenosine diphosphate‑ribose) polymerase‑related mechanism behind the apoptosis of the cells. These findings suggested that kin17 could become a novel target for breast cancer therapy.